Novel functions for dp214
OwnerCord E. Dohrmanninventor
Life of this patent
Estimating the term…
Loading patent…
OwnerCord E. Dohrmanninventor
Estimating the term…
The present invention discloses polynucleotides which identify and encode pDP214 as well as novel functions for the DP214 gene family (pDP214) which are specifically expressed specifically expressed in the mesenchyme of the developing pancreas, in the lung, the stomach, the kidney and specific areas of the ectoderm such as ectodermal ridge and hair follicles. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding pDP214 and a method for producing pDP214. The invention also provide for agonists, antibodies, or antagonists specifically binding, pDP214, and their, use, in the prevention and treatment of diseases associated with the expression of pDP214. Additionally, the invention provides for the use or antisense molecules to polynucleotides encoding pDP214 for the treatment or diseases associated with the expression of pDP214. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding pDP214.
A pharmaceutical composition comprising as an active agent a nucleic acid molecule of the DP214 gene family or a polypeptide encoded thereby or a fragment or variant of said nucleic acid molecule or said polypeptide or an antibody, aptamer or other receptor recognizing a nucleic acid molecule of the DP214 gene family or a polypeptide encoded thereby.
A recombinant host cell exhibiting a modified, e.g. increased or reduced expression of a DP214 polypeptide.
A method of identifying a polypeptide involved in diseases and disorders, for example, but not limited to, of the pancreas (such as diabetes), and related diseases and disorders (such as adipositas), of the pancreas, of the lung, of the stomach, of the kidney, of the skin or of appendages, and others in a mammal comprising the steps of
A method of screening for an agent which modulates the interaction of a DP214 polypeptide with a binding target/agent, comprising the steps of
Use of a nucleic acid molecule as depicted in SEQ ID, NO:
Dependencies are inferred from the claim text.